An Overview of Mantle Cell Lymphoma and Frontline Therapy
Expert panelists discuss a number of recent updates in B-cell lymphoma, particularly mantle cell lymphoma, follicular lymphoma and marginal zone lymphoma, that were presented at key conferences in 2021.
Now Viewing
EP: 1.An Overview of Mantle Cell Lymphoma and Frontline Therapy
EP: 2.Considerations for Selection and Use of Frontline Therapy in Mantle Cell Lymphoma
EP: 3.Second-Line Therapy for MCL: Differentiating Available BTK Inhibitors
EP: 4.CAR T-cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma
EP: 5.Optimizing MCL Management: Sequencing and Combination Strategies
EP: 6.Clinical Pearls in the Management of Mantle Cell Lymphoma
EP: 7.Pathophysiology of Follicular Lymphoma and Frontline Therapy
EP: 8.Novel Therapies and Treatment Selection in Patients With Relapsed/Refractory FL
EP: 9.PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
EP: 10.Optimizing the Sequencing of Therapy in Follicular Lymphoma
EP: 11.Clinical Pearls in the Management of Follicular Lymphoma
EP: 12.Frontline Treatment Options for Marginal Zone Lymphoma
EP: 13.Novel Treatment Strategies for Relapsed/Refractory MZL
EP: 14.Clinical Pearls in the Management of Marginal Zone Lymphoma
Related Videos
Related Content
